• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Diabetes

Embecta expands partnership with Direct Relief to support diabetes initiatives on World Diabetes Day

November 14, 2025 By Sean Whooley

Embecta BD U-500 insulin syringe

Embecta (Nasdaq:EMBC) today announced an expansion of its partnership with Direct Relief to mark World Diabetes Day. Today, Nov. 14, is World Diabetes Day, which marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. It also lands during the American Diabetes Association’s National Diabetes Awareness […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations Tagged With: embecta

What diabetes tech companies are doing on World Diabetes Day 2025

November 14, 2025 By Sean Whooley

World Diabetes day

Once again, World Diabetes Day, celebrated on Nov. 14 every year, has come around, highlighting new initiatives in the diabetes tech space. The date marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. It also lands during the American Diabetes Association’s National Diabetes Awareness Month. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, American Diabetes Association, Ascensia Diabetes Care, Breakthrough T1D, Dexcom, embecta, Insulet, Juvenile Diabetes Research Foundation (JDRF), Medtronic, Renu MedTech, Sequel Med Tech, ViCentra, World Diabetes Day 2025

Dexcom unveils new advocates to support World Diabetes Day campaign

November 14, 2025 By Sean Whooley

Dexcom World Diabetes Day map graphic

Dexcom (NSDQ:DXCM) today announced 16 new advocates representing people with diabetes as part of its World Diabetes Day campaign. Today, Nov. 14, is World Diabetes Day, which marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. It also lands during the American Diabetes Association’s National […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Renu MedTech introduces tubeless insulin patch pump in India

November 14, 2025 By Sean Whooley

Renu MedTech World Diabetes Day InsuPatch insulin patch pump (1)

Renu MedTech today unveiled InsuPatch, its tubeless insulin patch pump designed specifically for advancing diabetes care in India. On LinkedIn, the Pune, India-based company labeled InsuPatch “India’s first tubeless, affordable, patch-style insulin infusion pump.” “Diabetes touches millions of lives across India — shaping routines, emotions, families, and futures,” the company wrote. “For individuals who depend […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Renu MedTech

ViCentra highlights diabetes in the workplace on World Diabetes Day

November 14, 2025 By Sean Whooley

ViCentra Kaleido on arm

ViCentra today shared its own employees’ stories to highlight diabetes in the workplace on World Diabetes Day. Today, Nov. 14, is World Diabetes Day, which marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. It also lands during the American Diabetes Association’s National Diabetes Awareness Month. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: ViCentra

Glucotrack now expects spring 2026 FDA IDE submission for implantable CGM

November 13, 2025 By Sean Whooley

Glucotrack 3-year continuous blood glucose monitor (CBGM)

Glucotrack (Nasdaq:GCTK) today announced a slight delay in its plans to submit its long-term glucose monitor to the FDA for IDE. The company said in August that it expected a fourth-quarter investigational device exemption (IDE) submission for the long-term implantable continuous blood glucose monitor (CBGM). However, it says today that it anticipates a submission in […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Patient Monitoring, Technology Tagged With: Glucotrack

Carrot, Oura, Dexcom partner on biosensor insights for fertility

November 13, 2025 By Sean Whooley

A person wears the Oura ring while scrolling the app looking at glucose values.

Carrot announced that it partnered with Oura and Dexcom to deliver actionable, personalized insights supporting fertility goals. The companies came together to provide actionable, personalized insights through the metabolic-fertility program, Sprints. This collaboration combines Carrot’s clinical expertise with advanced insights from Oura, a leading smart wearable ring maker, and Dexcom, a leading continuous glucose monitor […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology, Women's Health Tagged With: carrot, Dexcom, Oura

Vivani to initiate study of semaglutide implant in 2026

November 13, 2025 By Sean Whooley

Vivani NanoPortal diabetes implant

Vivani Medical (Nasdaq:VANI) today announced third-quarter earnings results that included timeline updates on its semaglutide implant. The Alameda, California-based company develops NanoPortal technology, which steadily delivers medication over extended periods of time. Vivani aims to guarantee correct patient doses while avoiding potential safety concerns around fluctuating drug release profiles. It can also deliver large hydrophilic […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Implants, MassDevice Earnings Roundup, Technology Tagged With: Vivani Medical

What the launch of Mobi for Android means for Tandem, people with diabetes

November 12, 2025 By Sean Whooley

Tandem Diabetes Care Mobi Lifestyle

This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world’s smallest, durable automated insulin delivery system — to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Technology Tagged With: Tandem Diabetes Care

Go-Pen wins CE mark for user-fillable insulin pen

November 11, 2025 By Sean Whooley

Go-Pen insulin pen

Go-Pen announced today on social media that it received CE mark approval for its user-fillable insulin pen. The Denmark-based company said on LinkedIn that, with CE mark now in hand, adding to FDA clearance achieved in May, it now has the foundation needed to bring its insulin pen technology to the U.S. and European market. […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Regulatory/Compliance Tagged With: Go-Pen

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Interim pages omitted …
  • Page 203
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS